News

Hetero’s dolutegravir/lamivudine/tenofovir tablet prequalified

WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
 

  • HA696 - Dolutegravir/Lamivudine/Tenofovir disoproxil fumarate - 50mg/300mg/300mg - Tablet - Hetero Labs Limited - INDIA

 

Related Links